REG - Byotrol PLC - Board Changes

ByotrolAnnouncement

27/09/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230927:nRSa7478Na&default-theme=true

RNS Number : 7478N  Byotrol PLC  27 September 2023

 

Byotrol plc

("Byotrol" or the "Company")

Board Changes

Byotrol Plc (AIM: BYOT), the specialist infection prevention and control
company, announces that Vivan Pinto, CEO of the Company, has stepped down as
CEO and left the Company to pursue other opportunities.

 

David Traynor formerly Byotrol CEO 2013 - 2022 has kindly agreed to act as
interim CEO until a suitable replacement for Vivan is appointed.

 

 

Trevor Francis, Chairman of Byotrol, commented:

 

"From the time that Vivan took over from David Traynor as CEO, he was
committed to drive forward the Company strategy and build the organisation for
the exciting opportunities that we all believe are achievable. The Board
thanks Vivan for all his efforts over the last 20 months and would like to
wish Vivan well for the future".

 

 

Enquiries:

 

 Byotrol Plc
 Trevor Francis - Chairman                                             +44 (0)1925 742 000

 David Traynor - CEO
 Chris Sedwell - Chief Financial Officer

 Cavendish Capital Markets Limited (Nominated Adviser and Broker)      +44 (0)20 7220 0500
 Geoff Nash / George Dollemore - Corporate Finance
 Nigel Birks / Harriet Ward - ECM

 Flagstaff Strategic and Investor Communications                       +44 (0)20 7129 1474
 Tim Thompson/Andrea Seymour/Fergus Mellon                             byotrol@flagstaffcomms.com (mailto:byotrol@flagstaffcomms.com)

 

This announcement is released by Byotrol Plc and, prior to publication, the
information contained herein was deemed to constitute inside information under
the Market Abuse Regulations (EU) No. 596/2014. Such information is disclosed
in accordance with the Company's obligations under Article 17 of MAR.

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and
control company, operating globally in the Healthcare, Industrial, Food and
Consumer sectors, providing low toxicity products with a broad-based and
targeted efficacy across all microbial classes; bacteria, viruses (including
coronavirus), fungi, moulds, mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing
products, where they can significantly improve their performance, especially
in personal hygiene, domestic and industrial disinfection, odour control, food
production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and
cleaner lives for everyone.

 

For more information, go to byotrol.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAFLFITAFIRFIV